EU AI Act High-Risk Implementation Readiness
Use this skill when a system has already been classified as potentially high-risk under the EU AI Act and the user now needs to understand what must actually be implemented, documented, assigned, tested, and governed.
If the system has not yet been classified, use the EU AI Act System Classifier first.
This skill is designed as a practical readiness assessment and implementation navigator for:
- Providers of high-risk AI systems
- Deployers of high-risk AI systems
- Internal legal, compliance, product, engineering, security, risk, procurement, and management teams
- Especially DACH-based organizations preparing for real operational compliance work before the high-risk obligations apply
Important timing note: Annex III high-risk obligations apply from 2 December 2027 and Annex I product-integrated high-risk obligations from 2 August 2028. The Digital Omnibus simplification package amending the EU AI Act was adopted on 8 July 2026 and published in the Official Journal on 24 July 2026 as Regulation (EU) 2026/1744, entering into force on 27 July 2026; it deferred these dates from 2 August 2026 and 2 August 2027 respectively. Article 50 transparency obligations and the start of Commission GPAI enforcement powers were not deferred and continue to apply from 2 August 2026. Build against these enacted dates. The substance also moved in places: the same regulation amended Art. 10 and inserted Art. 4a. Article 4a(1) creates an exceptional bias-detection and correction basis for high-risk providers, subject to six safeguards. Article 4a(2) separately covers providers and deployers of other AI systems and models and deployers of high-risk AI systems, but only where processing is strictly necessary for biases likely to affect health or safety, negatively affect fundamental rights, or cause prohibited discrimination, and all paragraph 1 safeguards are applied; it creates no duty to conduct bias detection or correction. The regulation also amended Art. 11(1) (simplified technical documentation for SMEs and SMCs, which notified bodies must accept), Art. 17(2) and Art. 63(1) (quality-management proportionality and simplification), Art. 25(2) and (4) (provider-switch cooperation), Art. 43(3) (conformity-assessment routing, and sectoral notified bodies must apply for designation by 28 January 2028), Annex VIII Section B points 7 and 9 deleted (Art. 49(2) itself is unamended; the deletion reduces the information submitted for Art. 6(3) registrations), and Art. 72(3) (post-market monitoring template replaced by Commission guidance due 2 September 2027).
What this skill does
This skill helps the user answer five practical questions:
- Are we really in scope as high-risk?
- What obligations apply to us as provider, deployer, or both?
- What evidence and documentation should already exist?
- How ready are we today - RED, AMBER, or GREEN?
- What do we need to do next, in what order, and who should own it?
It covers operational readiness across the main Annex III lifecycle obligations, especially:
- Art. 6 and the Art. 6(3) exception context
- Arts. 9–15 provider controls
- Arts. 16–17 provider governance and QMS framing
- Art. 26 deployer obligations
- Art. 43 conformity assessment pathways
- Art. 49 EU database registration
- Art. 72 post-market monitoring
When to use this skill
Use this skill when the user asks things like:
- “We know the system is high-risk. What do we need to implement now?”
- “Can you assess our readiness for the EU AI Act?”
- “What evidence do we need for Annex III high-risk compliance?”
- “Create a gap analysis and implementation roadmap for our AI system.”
- “What do providers of high-risk AI need beyond classification?”
- “What do deployers need to do under Art. 26?”
- “Do we need a notified body or can we self-assess?”
- “How do we prepare technical documentation and QMS for a high-risk AI system?”
Quick intake questions
Start by collecting concise answers to these questions. If the user does not know, mark assumptions clearly.
A. Scope and role
- What does the AI system do in practice?
- Which Annex III category is believed to apply?
- Has the system already been classified using a separate high-risk classifier?
- Is there any argument that the Art. 6(3) exception applies, meaning the system may fall within Annex III wording but does not materially influence the decision-making in a way that makes it high-risk?
- Are you acting as provider, deployer, or both?
- Is the system already on the market / in service, in pilot phase, or still in development?
B. Organizational context
- Which legal entity owns the system and which teams operate it?
- In which countries will the system be placed on the market or used?
- Is the use case in a regulated sector such as employment, education, essential services, law enforcement, migration, justice, or biometric identification?
- Is this a standalone AI system, a component embedded in software, or integrated into a broader product/service?
C. Technical and control environment
- What data is used for training, validation, testing, and live operation?
- What logs are currently generated automatically?
- What human review or override exists today?
- What testing exists for accuracy, robustness, bias, and security?
- Is there already technical documentation, model documentation, validation documentation, or a QMS in place?
D. Governance and evidence
- Is there a named owner for compliance readiness?
- Is there a formal risk management process for the AI system?
- Are there supplier/vendor dependencies, including GPAI or third-party model providers?
- Is post-market monitoring already planned?
- Is management expecting a simple legal memo or an implementation-grade roadmap with evidence requirements?
Decision tree: start here
Step 1 - Confirm classification posture
- If the system has not yet been classified, stop and direct the user to the EU AI Act System Classifier first.
- If the system appears to match Annex III but there may be a credible Art. 6(3) exception argument, do not proceed as if high-risk is settled. Flag the issue and recommend a focused classification memo before readiness work continues.
- If the system is reasonably treated as high-risk, continue.
Step 2 - Determine actor posture
- If the organization develops / places on the market / puts into service under its own name, assess provider obligations.
- If the organization uses the system in its operations, assess deployer obligations.
- If it does both, run both tracks and separate deliverables clearly.
Step 3 - Determine assessment mode
Choose one of three modes:
- Rapid triage - fast RED/AMBER/GREEN scan across all obligation areas
- Evidence-based readiness assessment - assess each area against actual documents, processes, owners, and controls
- Implementation roadmap - turn identified gaps into a sequenced action plan with owners, dependencies, and deliverables
Step 4 - Determine conformity assessment path
- For Annex III point 1, Annex VI or Annex VII is available only where all relevant harmonised standards or common specifications are applied; otherwise Annex VII applies.
- For Annex III points 2 to 8, Article 43(2) requires Annex VI internal control with no notified body.
- For Annex I Section A products, follow the sectoral conformity-assessment route under Article 43(3). For Annex I Section B products, account for the limited AI Act application stated in Article 2(2).
- If unclear, flag this early because it changes evidence expectations and timelines
Core workflow
1. Frame the scope precisely
Produce a short scoping statement covering:
- system name / working label
- practical function
- likely Annex III category
- provider/deployer role split
- lifecycle stage
- jurisdictions
- whether Art. 6(3) remains open or has been ruled out
Output at this stage: one-paragraph scope statement + assumption list.
2. Assess readiness across the 12 obligation areas
For each area below, evaluate:
- What the AI Act requires
- What evidence should exist
- Readiness status: RED / AMBER / GREEN
- Key gaps
- Next actions
- Common pitfalls
Area 1 - Risk management system (Art. 9)
Ask:
- Is there a defined AI-specific risk management process across the lifecycle?
- Are known and reasonably foreseeable risks identified and documented?
- Are risk controls tied to testing, design, and residual risk evaluation?
- Are changes, incidents, and monitoring findings fed back into the system?
Evidence examples:
- risk management procedure
- system risk register
- hazard / harm analysis
- control mapping
- residual risk sign-off
- validation and test evidence
Use deep dive: references/risk-management-system.md
Area 2 - Data governance and data quality (Art. 10)
Ask:
- What datasets were used for training, validation, and testing?
- Are relevance, representativeness, completeness, and error considerations documented?
- Was bias examination performed and recorded?
- Is data provenance and acquisition legality documented?
Evidence examples:
- dataset inventory
- data specification sheets
- bias assessment
- sampling rationale
- data cleaning and labeling procedures
- validation dataset design notes
Use deep dive: references/data-governance.md
Area 3 - Technical documentation (Art. 11 + Annex IV)
Ask:
- Could the organization produce a defensible Annex IV-style technical file today?
- Is system design, development method, intended purpose, architecture, metrics, risk controls, and change history documented?
- Are monitoring capabilities and limitations explained clearly enough for review?
Evidence examples:
- technical file / Annex IV pack
- architecture diagrams
- model cards / system cards
- development and validation methodology
- version/change log
- limitations and assumptions documentation
Use deep dive: references/technical-documentation.md
Area 4 - Record-keeping and logging (Art. 12)
Ask:
- What logs are created automatically?
- Do logs support traceability for operation, incidents, human intervention, and review?
- Is retention aligned with legal and operational needs?
- Can logs support investigations and post-market monitoring?
Evidence examples:
- logging specification
- event taxonomy
- retention schedule
- access controls for logs
- sample audit trail outputs
Area 5 - Transparency and information to deployers (Art. 13)
Ask:
- Are there instructions for use?
- Are intended purpose, operating conditions, known limitations, expected accuracy, oversight assumptions, and security conditions explained?
- Would a deployer know when the system should not be used?
Evidence examples:
- instructions for use
- deployment manual
- limitation statements
- accuracy/robustness documentation
- user-facing warnings and assumptions
Area 6 - Human oversight (Art. 14)
Ask:
- Who is expected to oversee the system?
- Can they understand outputs well enough to intervene meaningfully?
- Is there a stop, override, or escalation mechanism?
- Is oversight designed into the process rather than assumed abstractly?
Evidence examples:
- oversight design specification
- SOPs for reviewers/operators
- override or manual fallback procedures
- training materials
- escalation matrix
Area 7 - Accuracy, robustness, and cybersecurity (Art. 15)
Ask:
- What performance thresholds are defined?
- How was robustness tested under foreseeable operating conditions?
- What error handling and fail-safe logic exists?
- What cybersecurity risks, including adversarial manipulation, have been considered?
Evidence examples:
- performance benchmarks
- validation reports
- robustness/stress testing
- security testing results
- vulnerability management records
Area 8 - Quality management system (Art. 17)
Ask:
- Is there a documented QMS covering the AI lifecycle?
- Are design, development, testing, change management, supplier control, incident handling, and authority communication governed?
- Are roles and records assigned in a way that can survive audit or conformity review?
Evidence examples:
- QMS manual
- policies and procedures
- role matrix / RACI
- change control procedure
- supplier management records
- CAPA / incident process
Use deep dive: references/qms-requirements.md
Area 9 - Deployer obligations (Art. 26)
Ask:
- Is the system being used in accordance with the provider’s instructions?
- Are human oversight responsibilities assigned?
- Is input data checked for relevance and suitability?
- Are records maintained during use?
- Are affected persons informed where required?
- Is a fundamental rights impact assessment required under Art. 27(1): is the deployer a public-law body or private public-service entity, or is the system an Annex III point 5(b) creditworthiness/credit-scoring or point 5(c) life/health-insurance system (where every deployer owes the FRIA)? Annex III point 2 is excepted.
Evidence examples:
- deployer SOPs
- user governance record
- oversight assignments
- operational monitoring logs
- notice/information materials
- FRIA documentation where relevant
Use deep dive: references/deployer-obligations.md
Area 10 - Conformity assessment path (Art. 43)
Ask:
- Is the system likely on the Annex VI internal control route?
- Is third-party assessment / notified body involvement required?
- What evidence package would be expected under the chosen route?
- Who owns the conformity assessment timeline?
Evidence examples:
- classification memo
- conformity assessment path memo
- Annex VI checklist
- notified body engagement plan if needed
Use deep dive: references/conformity-assessment.md
Area 11 - Post-market monitoring (Art. 72)
Ask:
- Is there a documented, proportionate post-market monitoring plan?
- What data will be collected from live operation?
- How are incidents, malfunctions, and performance drift analyzed?
- How do findings feed back into risk management, documentation, and controls?
Evidence examples:
- post-market monitoring plan
- KPI/KRI definitions
- incident intake workflow
- review cadence and reporting structure
Area 12 - EU database registration (Art. 49)
Ask:
- Who is responsible for registration before placing on the market or putting into service?
- Is the required registration data known and assembled?
- Is registration integrated into launch governance?
Evidence examples:
- registration readiness checklist
- responsibility assignment
- pre-launch gate / approval workflow
3. Apply the readiness scoring model
Use this scoring consistently for every area.
RED - Not started / materially deficient
Use RED where one or more of the following is true:
- no documented process exists
- no owner is assigned
- evidence is missing or purely informal
- controls exist in practice but are not systematic, documented, or reviewable
- the organization could not defend the area in a conformity assessment or authority inquiry
AMBER - Partially addressed / not yet defensible end-to-end
Use AMBER where:
- some controls exist but are fragmented
- evidence exists but is incomplete, inconsistent, outdated, or not AI-specific
- roles are partly assigned but not embedded operationally
- testing or monitoring exists but is not tied back to governance and risk decisions
GREEN - Substantially ready
Use GREEN where:
- the process is defined, operational, and documented
- evidence is current and reviewable
- ownership is assigned
- the area is integrated into lifecycle governance
- there are still improvement opportunities, but the organization is broadly defensible
Do not mark GREEN purely because “the team is already careful” or “similar controls exist somewhere else.”
4. Identify critical dependencies and blockers
After scoring, identify blockers such as:
- unresolved Art. 6(3) scope question
- unclear provider vs deployer role split
- lack of named accountable owner
- no technical documentation baseline
- no AI-specific risk register
- insufficient logging or traceability
- no oversight design
- reliance on a third-party model/vendor with weak documentation support
- missing QMS backbone
- unclear conformity assessment path
Group blockers into:
- Legal/classification blockers
- Process/governance blockers
- Technical/control blockers
- Evidence/documentation blockers
5. Build a practical implementation roadmap
Translate gaps into a sequenced roadmap.
Recommended workstreams:
- Scope and accountability
- Risk management
- Data governance
- Documentation and logging
- Human oversight and operations
- Testing, robustness, and cybersecurity
- QMS and authority-facing readiness
- Deployer operating model
- Conformity assessment and registration
- Post-market monitoring
For each workstream define:
- objective
- key deliverables
- owner
- supporting teams
- dependencies
- target timing
- residual decision points
Use templates in references/templates.md.
6. Tailor for DACH implementation reality
Where relevant, add practical DACH-specific points such as:
- likely interaction with German market surveillance or sector regulators
- BNetzA / BSI / sector authority interfaces depending on use case
- procurement and documentation expectations in German enterprises
- works council implications where human oversight affects employees or AI is used in HR contexts
- need for German-language operational materials, training, or works agreements in practice
Use: references/dach-specific.md
Practical shortcuts and pitfalls to flag
Always call out shortcuts that look attractive but are weak in a real assessment.
Common examples:
- “We already have ISO processes, so we must be compliant.”
- “We have general model docs, so that counts as Annex IV technical documentation.”
- “Humans review sometimes” without defining who, when, with what authority, and based on what criteria.
- “Security reviewed the app” without AI-specific robustness and adversarial considerations.
- “We keep logs” without confirming traceability, access, retention, and useful event design.
- “The vendor handles compliance” without obtaining evidence and role clarity.
- “We’ll write the documents later” when core controls are not yet actually operating.
Output format
Unless the user asks for something else, structure the final deliverable like this:
1. Executive summary
- in-scope system and role
- high-level conclusion on readiness
- top 3–5 critical gaps
- immediate next actions
2. Scope and assumptions
- system description
- likely Annex III category
- provider/deployer split
- Art. 6(3) position if relevant
- assumptions / unknowns
3. Readiness scorecard
For each of the 12 areas:
- requirement summary
- expected evidence
- status: RED / AMBER / GREEN
- rationale
- immediate next step
4. Priority gap analysis
- critical gaps
- why they matter
- dependencies and sequencing
5. Implementation roadmap
- 30 / 60 / 90 day view, or phased workstream plan
- owners and dependencies
6. DACH-specific notes
- regulator / authority / works council / operational localization issues
7. Key caveats
- legal uncertainties
- evidence limitations
- any items needing specialist legal or technical validation
Suggested response patterns
If the user wants a quick assessment
Provide:
- brief scope statement
- 12-area RED/AMBER/GREEN scorecard
- top 5 actions
- biggest conformity assessment risk
If the user wants implementation help
Provide:
- scorecard
- gap analysis
- detailed roadmap
- document list to create
- owner suggestions by function
If the user is a deployer only
Focus more heavily on:
- Art. 26 usage controls
- provider instruction adherence
- oversight assignment
- monitoring and record-keeping in operation
- FRIA / affected-person information where relevant
If the user is a provider with a mature quality function
Focus more heavily on:
- evidence sufficiency
- AI-specific adaptations to existing QMS
- Annex IV technical documentation completeness
- risk management lifecycle integration
- conformity assessment readiness
Recommended reference map
Use these deep dives selectively rather than overloading the main response:
references/risk-management-system.md
references/data-governance.md
references/technical-documentation.md
references/qms-requirements.md
references/conformity-assessment.md
references/deployer-obligations.md
references/dach-specific.md
references/templates.md
Legacy systems: the grace period moved (Article 111(2))
Regulation (EU) 2026/1744 replaced Article 111(2) on 27 July 2026, and this matters
directly for question 6 of the intake above.
The cut-off is no longer the fixed date of 2 August 2026. It now tracks the date of
application of Chapter III under Article 113, meaning 2 December 2027 for Annex III
systems and 2 August 2028 for Annex I systems. A high-risk system already placed on the
market or put into service before its applicable date falls outside the requirements unless
it is subject to significant changes in its design from that date onward.
Two qualifications that decide most real cases:
- The grace period is assessed for systems individually placed on the market or put into
service before the applicable date. Later units of the same type or model that are first
supplied after that date are not grandfathered merely because an earlier unit was supplied.
- Public-authority deployments have their own hard stop. Providers and deployers of
high-risk systems intended for use by public authorities must comply by 2 August 2030
regardless, and that date did not move.
Practical readiness consequence: record the placement-on-market or putting-into-service
date for each system or unit relied upon, together with its design baseline. For an existing
system, also ask whether a significant design change will occur from the applicable date.
Disclaimer
This skill provides a practical implementation and readiness framework for the EU AI Act, especially for Annex III high-risk systems. It is not a substitute for formal legal advice, sector-specific regulatory advice, technical assurance, cybersecurity testing, or notified-body input where required.
The AI Act contains cross-references, implementing acts, harmonized standards, and evolving guidance that may change how obligations are interpreted in practice. Where classification is uncertain, where the Art. 6(3) exception may apply, where biometric or sector-specific issues are involved, or where conformity assessment route selection is unclear, the user should validate the position with qualified counsel and relevant technical stakeholders.
What good looks like
A strong outcome from this skill is not just “a compliance memo.” It is:
- a clear scope position
- a defensible readiness score by obligation area
- a concrete evidence list
- a prioritized implementation roadmap
- named ownership
- a practical path toward conformity assessment, deployment readiness, and ongoing monitoring
That is the difference between knowing you are high-risk and being operationally prepared for it.
1---2name: eu-ai-act-high-risk-implementation-readiness3description: Assess and operationalize implementation readiness for high-risk AI systems under the EU AI Act Annex III, including provider and deployer obligations, conformity assessment, post-market monitoring, and EU database registration. Use when users say things like “we classified this as high-risk, what now?”, “build an EU AI Act readiness plan”, “assess our Annex III compliance gaps”, “what do providers/deployers of high-risk AI need to implement?”, “prepare for conformity assessment”, or “create a high-risk AI implementation roadmap.”4---5
6# EU AI Act High-Risk Implementation Readiness
7
8Use this skill when a system has already been classified as potentially high-risk under the EU AI Act and the user now needs to understand what must actually be implemented, documented, assigned, tested, and governed.
9
10If the system has **not** yet been classified, use the **EU AI Act System Classifier** first.
11
12This skill is designed as a **practical readiness assessment and implementation navigator** for:
13- **Providers** of high-risk AI systems
14- **Deployers** of high-risk AI systems
15- Internal legal, compliance, product, engineering, security, risk, procurement, and management teams
16- Especially **DACH-based organizations** preparing for real operational compliance work before the high-risk obligations apply
17
18> Important timing note: Annex III high-risk obligations apply from **2 December 2027** and Annex I product-integrated high-risk obligations from **2 August 2028**. The Digital Omnibus simplification package amending the EU AI Act was adopted on 8 July 2026 and published in the Official Journal on 24 July 2026 as Regulation (EU) 2026/1744, entering into force on 27 July 2026; it deferred these dates from 2 August 2026 and 2 August 2027 respectively. Article 50 transparency obligations and the start of Commission GPAI enforcement powers were not deferred and continue to apply from 2 August 2026. Build against these enacted dates. The substance also moved in places: the same regulation amended Art. 10 and inserted Art. 4a. Article 4a(1) creates an exceptional bias-detection and correction basis for high-risk providers, subject to six safeguards. Article 4a(2) separately covers providers and deployers of other AI systems and models and deployers of high-risk AI systems, but only where processing is strictly necessary for biases likely to affect health or safety, negatively affect fundamental rights, or cause prohibited discrimination, and all paragraph 1 safeguards are applied; it creates no duty to conduct bias detection or correction. The regulation also amended Art. 11(1) (simplified technical documentation for SMEs and SMCs, which notified bodies must accept), Art. 17(2) and Art. 63(1) (quality-management proportionality and simplification), Art. 25(2) and (4) (provider-switch cooperation), Art. 43(3) (conformity-assessment routing, and sectoral notified bodies must apply for designation by 28 January 2028), Annex VIII Section B points 7 and 9 deleted (Art. 49(2) itself is unamended; the deletion reduces the information submitted for Art. 6(3) registrations), and Art. 72(3) (post-market monitoring template replaced by Commission guidance due 2 September 2027).
19
20---
21
22## What this skill does
23
24This skill helps the user answer five practical questions:
25
261. **Are we really in scope as high-risk?**
272. **What obligations apply to us as provider, deployer, or both?**
283. **What evidence and documentation should already exist?**
294. **How ready are we today - RED, AMBER, or GREEN?**
305. **What do we need to do next, in what order, and who should own it?**
31
32It covers operational readiness across the main Annex III lifecycle obligations, especially:
33- Art. 6 and the Art. 6(3) exception context
34- Arts. 9–15 provider controls
35- Arts. 16–17 provider governance and QMS framing
36- Art. 26 deployer obligations
37- Art. 43 conformity assessment pathways
38- Art. 49 EU database registration
39- Art. 72 post-market monitoring
40
41---
42
43## When to use this skill
44
45Use this skill when the user asks things like:
46- “We know the system is high-risk. What do we need to implement now?”
47- “Can you assess our readiness for the EU AI Act?”
48- “What evidence do we need for Annex III high-risk compliance?”
49- “Create a gap analysis and implementation roadmap for our AI system.”
50- “What do providers of high-risk AI need beyond classification?”
51- “What do deployers need to do under Art. 26?”
52- “Do we need a notified body or can we self-assess?”
53- “How do we prepare technical documentation and QMS for a high-risk AI system?”
54
55---
56
57## Quick intake questions
58
59Start by collecting concise answers to these questions. If the user does not know, mark assumptions clearly.
60
61### A. Scope and role
621. What does the AI system do in practice?
632. Which Annex III category is believed to apply?
643. Has the system already been classified using a separate high-risk classifier?
654. Is there any argument that the **Art. 6(3) exception** applies, meaning the system may fall within Annex III wording but does **not** materially influence the decision-making in a way that makes it high-risk?
665. Are you acting as **provider**, **deployer**, or both?
676. Is the system already on the market / in service, in pilot phase, or still in development?
68
69### B. Organizational context
707. Which legal entity owns the system and which teams operate it?
718. In which countries will the system be placed on the market or used?
729. Is the use case in a regulated sector such as employment, education, essential services, law enforcement, migration, justice, or biometric identification?
7310. Is this a standalone AI system, a component embedded in software, or integrated into a broader product/service?
74
75### C. Technical and control environment
7611. What data is used for training, validation, testing, and live operation?
7712. What logs are currently generated automatically?
7813. What human review or override exists today?
7914. What testing exists for accuracy, robustness, bias, and security?
8015. Is there already technical documentation, model documentation, validation documentation, or a QMS in place?
81
82### D. Governance and evidence
8316. Is there a named owner for compliance readiness?
8417. Is there a formal risk management process for the AI system?
8518. Are there supplier/vendor dependencies, including GPAI or third-party model providers?
8619. Is post-market monitoring already planned?
8720. Is management expecting a simple legal memo or an implementation-grade roadmap with evidence requirements?
88
89---
90
91## Decision tree: start here
92
93### Step 1 - Confirm classification posture
94- If the system has **not yet been classified**, stop and direct the user to the **EU AI Act System Classifier** first.
95- If the system appears to match Annex III but there may be a credible **Art. 6(3) exception** argument, do **not** proceed as if high-risk is settled. Flag the issue and recommend a focused classification memo before readiness work continues.
96- If the system is reasonably treated as high-risk, continue.
97
98### Step 2 - Determine actor posture
99- If the organization **develops / places on the market / puts into service under its own name**, assess **provider obligations**.
100- If the organization **uses** the system in its operations, assess **deployer obligations**.
101- If it does both, run both tracks and separate deliverables clearly.
102
103### Step 3 - Determine assessment mode
104Choose one of three modes:
105- **Rapid triage** - fast RED/AMBER/GREEN scan across all obligation areas
106- **Evidence-based readiness assessment** - assess each area against actual documents, processes, owners, and controls
107- **Implementation roadmap** - turn identified gaps into a sequenced action plan with owners, dependencies, and deliverables
108
109### Step 4 - Determine conformity assessment path
110- For **Annex III point 1**, Annex VI or Annex VII is available only where all relevant harmonised standards or common specifications are applied; otherwise Annex VII applies.
111- For **Annex III points 2 to 8**, Article 43(2) requires Annex VI internal control with no notified body.
112- For **Annex I Section A** products, follow the sectoral conformity-assessment route under Article 43(3). For **Annex I Section B** products, account for the limited AI Act application stated in Article 2(2).
113- If unclear, flag this early because it changes evidence expectations and timelines
114
115---
116
117## Core workflow
118
119### 1. Frame the scope precisely
120Produce a short scoping statement covering:
121- system name / working label
122- practical function
123- likely Annex III category
124- provider/deployer role split
125- lifecycle stage
126- jurisdictions
127- whether Art. 6(3) remains open or has been ruled out
128
129**Output at this stage:** one-paragraph scope statement + assumption list.
130
131---
132
133### 2. Assess readiness across the 12 obligation areas
134For each area below, evaluate:
135- **What the AI Act requires**
136- **What evidence should exist**
137- **Readiness status:** RED / AMBER / GREEN
138- **Key gaps**
139- **Next actions**
140- **Common pitfalls**
141
142#### Area 1 - Risk management system (Art. 9)
143Ask:
144- Is there a defined AI-specific risk management process across the lifecycle?
145- Are known and reasonably foreseeable risks identified and documented?
146- Are risk controls tied to testing, design, and residual risk evaluation?
147- Are changes, incidents, and monitoring findings fed back into the system?
148
149Evidence examples:
150- risk management procedure
151- system risk register
152- hazard / harm analysis
153- control mapping
154- residual risk sign-off
155- validation and test evidence
156
157Use deep dive: `references/risk-management-system.md`
158
159#### Area 2 - Data governance and data quality (Art. 10)
160Ask:
161- What datasets were used for training, validation, and testing?
162- Are relevance, representativeness, completeness, and error considerations documented?
163- Was bias examination performed and recorded?
164- Is data provenance and acquisition legality documented?
165
166Evidence examples:
167- dataset inventory
168- data specification sheets
169- bias assessment
170- sampling rationale
171- data cleaning and labeling procedures
172- validation dataset design notes
173
174Use deep dive: `references/data-governance.md`
175
176#### Area 3 - Technical documentation (Art. 11 + Annex IV)
177Ask:
178- Could the organization produce a defensible Annex IV-style technical file today?
179- Is system design, development method, intended purpose, architecture, metrics, risk controls, and change history documented?
180- Are monitoring capabilities and limitations explained clearly enough for review?
181
182Evidence examples:
183- technical file / Annex IV pack
184- architecture diagrams
185- model cards / system cards
186- development and validation methodology
187- version/change log
188- limitations and assumptions documentation
189
190Use deep dive: `references/technical-documentation.md`
191
192#### Area 4 - Record-keeping and logging (Art. 12)
193Ask:
194- What logs are created automatically?
195- Do logs support traceability for operation, incidents, human intervention, and review?
196- Is retention aligned with legal and operational needs?
197- Can logs support investigations and post-market monitoring?
198
199Evidence examples:
200- logging specification
201- event taxonomy
202- retention schedule
203- access controls for logs
204- sample audit trail outputs
205
206#### Area 5 - Transparency and information to deployers (Art. 13)
207Ask:
208- Are there instructions for use?
209- Are intended purpose, operating conditions, known limitations, expected accuracy, oversight assumptions, and security conditions explained?
210- Would a deployer know when the system should not be used?
211
212Evidence examples:
213- instructions for use
214- deployment manual
215- limitation statements
216- accuracy/robustness documentation
217- user-facing warnings and assumptions
218
219#### Area 6 - Human oversight (Art. 14)
220Ask:
221- Who is expected to oversee the system?
222- Can they understand outputs well enough to intervene meaningfully?
223- Is there a stop, override, or escalation mechanism?
224- Is oversight designed into the process rather than assumed abstractly?
225
226Evidence examples:
227- oversight design specification
228- SOPs for reviewers/operators
229- override or manual fallback procedures
230- training materials
231- escalation matrix
232
233#### Area 7 - Accuracy, robustness, and cybersecurity (Art. 15)
234Ask:
235- What performance thresholds are defined?
236- How was robustness tested under foreseeable operating conditions?
237- What error handling and fail-safe logic exists?
238- What cybersecurity risks, including adversarial manipulation, have been considered?
239
240Evidence examples:
241- performance benchmarks
242- validation reports
243- robustness/stress testing
244- security testing results
245- vulnerability management records
246
247#### Area 8 - Quality management system (Art. 17)
248Ask:
249- Is there a documented QMS covering the AI lifecycle?
250- Are design, development, testing, change management, supplier control, incident handling, and authority communication governed?
251- Are roles and records assigned in a way that can survive audit or conformity review?
252
253Evidence examples:
254- QMS manual
255- policies and procedures
256- role matrix / RACI
257- change control procedure
258- supplier management records
259- CAPA / incident process
260
261Use deep dive: `references/qms-requirements.md`
262
263#### Area 9 - Deployer obligations (Art. 26)
264Ask:
265- Is the system being used in accordance with the provider’s instructions?
266- Are human oversight responsibilities assigned?
267- Is input data checked for relevance and suitability?
268- Are records maintained during use?
269- Are affected persons informed where required?
270- Is a **fundamental rights impact assessment** required under Art. 27(1): is the deployer a public-law body or private public-service entity, or is the system an Annex III point 5(b) creditworthiness/credit-scoring or point 5(c) life/health-insurance system (where every deployer owes the FRIA)? Annex III point 2 is excepted.
271
272Evidence examples:
273- deployer SOPs
274- user governance record
275- oversight assignments
276- operational monitoring logs
277- notice/information materials
278- FRIA documentation where relevant
279
280Use deep dive: `references/deployer-obligations.md`
281
282#### Area 10 - Conformity assessment path (Art. 43)
283Ask:
284- Is the system likely on the Annex VI internal control route?
285- Is third-party assessment / notified body involvement required?
286- What evidence package would be expected under the chosen route?
287- Who owns the conformity assessment timeline?
288
289Evidence examples:
290- classification memo
291- conformity assessment path memo
292- Annex VI checklist
293- notified body engagement plan if needed
294
295Use deep dive: `references/conformity-assessment.md`
296
297#### Area 11 - Post-market monitoring (Art. 72)
298Ask:
299- Is there a documented, proportionate post-market monitoring plan?
300- What data will be collected from live operation?
301- How are incidents, malfunctions, and performance drift analyzed?
302- How do findings feed back into risk management, documentation, and controls?
303
304Evidence examples:
305- post-market monitoring plan
306- KPI/KRI definitions
307- incident intake workflow
308- review cadence and reporting structure
309
310#### Area 12 - EU database registration (Art. 49)
311Ask:
312- Who is responsible for registration before placing on the market or putting into service?
313- Is the required registration data known and assembled?
314- Is registration integrated into launch governance?
315
316Evidence examples:
317- registration readiness checklist
318- responsibility assignment
319- pre-launch gate / approval workflow
320
321---
322
323### 3. Apply the readiness scoring model
324Use this scoring consistently for every area.
325
326#### RED - Not started / materially deficient
327Use RED where one or more of the following is true:
328- no documented process exists
329- no owner is assigned
330- evidence is missing or purely informal
331- controls exist in practice but are not systematic, documented, or reviewable
332- the organization could not defend the area in a conformity assessment or authority inquiry
333
334#### AMBER - Partially addressed / not yet defensible end-to-end
335Use AMBER where:
336- some controls exist but are fragmented
337- evidence exists but is incomplete, inconsistent, outdated, or not AI-specific
338- roles are partly assigned but not embedded operationally
339- testing or monitoring exists but is not tied back to governance and risk decisions
340
341#### GREEN - Substantially ready
342Use GREEN where:
343- the process is defined, operational, and documented
344- evidence is current and reviewable
345- ownership is assigned
346- the area is integrated into lifecycle governance
347- there are still improvement opportunities, but the organization is broadly defensible
348
349Do **not** mark GREEN purely because “the team is already careful” or “similar controls exist somewhere else.”
350
351---
352
353### 4. Identify critical dependencies and blockers
354After scoring, identify blockers such as:
355- unresolved Art. 6(3) scope question
356- unclear provider vs deployer role split
357- lack of named accountable owner
358- no technical documentation baseline
359- no AI-specific risk register
360- insufficient logging or traceability
361- no oversight design
362- reliance on a third-party model/vendor with weak documentation support
363- missing QMS backbone
364- unclear conformity assessment path
365
366Group blockers into:
367- **Legal/classification blockers**
368- **Process/governance blockers**
369- **Technical/control blockers**
370- **Evidence/documentation blockers**
371
372---
373
374### 5. Build a practical implementation roadmap
375Translate gaps into a sequenced roadmap.
376
377Recommended workstreams:
3781. **Scope and accountability**
3792. **Risk management**
3803. **Data governance**
3814. **Documentation and logging**
3825. **Human oversight and operations**
3836. **Testing, robustness, and cybersecurity**
3847. **QMS and authority-facing readiness**
3858. **Deployer operating model**
3869. **Conformity assessment and registration**
38710. **Post-market monitoring**
388
389For each workstream define:
390- objective
391- key deliverables
392- owner
393- supporting teams
394- dependencies
395- target timing
396- residual decision points
397
398Use templates in `references/templates.md`.
399
400---
401
402### 6. Tailor for DACH implementation reality
403Where relevant, add practical DACH-specific points such as:
404- likely interaction with German market surveillance or sector regulators
405- BNetzA / BSI / sector authority interfaces depending on use case
406- procurement and documentation expectations in German enterprises
407- works council implications where human oversight affects employees or AI is used in HR contexts
408- need for German-language operational materials, training, or works agreements in practice
409
410Use: `references/dach-specific.md`
411
412---
413
414## Practical shortcuts and pitfalls to flag
415
416Always call out shortcuts that look attractive but are weak in a real assessment.
417
418Common examples:
419- “We already have ISO processes, so we must be compliant.”
420- “We have general model docs, so that counts as Annex IV technical documentation.”
421- “Humans review sometimes” without defining who, when, with what authority, and based on what criteria.
422- “Security reviewed the app” without AI-specific robustness and adversarial considerations.
423- “We keep logs” without confirming traceability, access, retention, and useful event design.
424- “The vendor handles compliance” without obtaining evidence and role clarity.
425- “We’ll write the documents later” when core controls are not yet actually operating.
426
427---
428
429## Output format
430
431Unless the user asks for something else, structure the final deliverable like this:
432
433### 1. Executive summary
434- in-scope system and role
435- high-level conclusion on readiness
436- top 3–5 critical gaps
437- immediate next actions
438
439### 2. Scope and assumptions
440- system description
441- likely Annex III category
442- provider/deployer split
443- Art. 6(3) position if relevant
444- assumptions / unknowns
445
446### 3. Readiness scorecard
447For each of the 12 areas:
448- requirement summary
449- expected evidence
450- status: RED / AMBER / GREEN
451- rationale
452- immediate next step
453
454### 4. Priority gap analysis
455- critical gaps
456- why they matter
457- dependencies and sequencing
458
459### 5. Implementation roadmap
460- 30 / 60 / 90 day view, or phased workstream plan
461- owners and dependencies
462
463### 6. DACH-specific notes
464- regulator / authority / works council / operational localization issues
465
466### 7. Key caveats
467- legal uncertainties
468- evidence limitations
469- any items needing specialist legal or technical validation
470
471---
472
473## Suggested response patterns
474
475### If the user wants a quick assessment
476Provide:
477- brief scope statement
478- 12-area RED/AMBER/GREEN scorecard
479- top 5 actions
480- biggest conformity assessment risk
481
482### If the user wants implementation help
483Provide:
484- scorecard
485- gap analysis
486- detailed roadmap
487- document list to create
488- owner suggestions by function
489
490### If the user is a deployer only
491Focus more heavily on:
492- Art. 26 usage controls
493- provider instruction adherence
494- oversight assignment
495- monitoring and record-keeping in operation
496- FRIA / affected-person information where relevant
497
498### If the user is a provider with a mature quality function
499Focus more heavily on:
500- evidence sufficiency
501- AI-specific adaptations to existing QMS
502- Annex IV technical documentation completeness
503- risk management lifecycle integration
504- conformity assessment readiness
505
506---
507
508## Recommended reference map
509
510Use these deep dives selectively rather than overloading the main response:
511- `references/risk-management-system.md`
512- `references/data-governance.md`
513- `references/technical-documentation.md`
514- `references/qms-requirements.md`
515- `references/conformity-assessment.md`
516- `references/deployer-obligations.md`
517- `references/dach-specific.md`
518- `references/templates.md`
519
520---
521
522## Legacy systems: the grace period moved (Article 111(2))
523
524Regulation (EU) 2026/1744 replaced Article 111(2) on 27 July 2026, and this matters
525directly for question 6 of the intake above.
526
527The cut-off is no longer the fixed date of 2 August 2026. It now tracks the date of
528application of Chapter III under Article 113, meaning **2 December 2027** for Annex III
529systems and **2 August 2028** for Annex I systems. A high-risk system already placed on the
530market or put into service before its applicable date falls outside the requirements unless
531it is subject to significant changes in its design from that date onward.
532
533Two qualifications that decide most real cases:
534
535- **The grace period is assessed for systems individually placed on the market or put into
536 service before the applicable date.** Later units of the same type or model that are first
537 supplied after that date are not grandfathered merely because an earlier unit was supplied.
538- **Public-authority deployments have their own hard stop.** Providers and deployers of
539 high-risk systems intended for use by public authorities must comply by **2 August 2030**
540 regardless, and that date did not move.
541
542Practical readiness consequence: record the placement-on-market or putting-into-service
543date for each system or unit relied upon, together with its design baseline. For an existing
544system, also ask whether a significant design change will occur from the applicable date.
545
546## Disclaimer
547
548This skill provides a practical implementation and readiness framework for the EU AI Act, especially for Annex III high-risk systems. It is not a substitute for formal legal advice, sector-specific regulatory advice, technical assurance, cybersecurity testing, or notified-body input where required.
549
550The AI Act contains cross-references, implementing acts, harmonized standards, and evolving guidance that may change how obligations are interpreted in practice. Where classification is uncertain, where the Art. 6(3) exception may apply, where biometric or sector-specific issues are involved, or where conformity assessment route selection is unclear, the user should validate the position with qualified counsel and relevant technical stakeholders.
551
552---
553
554## What good looks like
555
556A strong outcome from this skill is not just “a compliance memo.” It is:
557- a clear scope position
558- a defensible readiness score by obligation area
559- a concrete evidence list
560- a prioritized implementation roadmap
561- named ownership
562- a practical path toward conformity assessment, deployment readiness, and ongoing monitoring
563
564That is the difference between knowing you are high-risk and being operationally prepared for it.